Advertisement

Topics

Advent Venture Partners Company Profile

11:13 EST 11th December 2018 | BioPortfolio

Advent Venture Partners is one of the most experienced technology venture capital firms in the UK. Established in 1981 it invests in both the Information and Communications Technology and Life Sciences sectors. Now in its 25th year Advent has over £500 million under management from institutional investors across Europe and the USA.

Location

25 Buckingham Gate
London
London
SW1E 6LD
United Kingdom

Contact

Phone: 44 (0)20 7932 2100
Fax: 44 (0)20 7828 1474
Email: info@adventventures.com


News Articles [417 Associated News Articles listed on BioPortfolio]

M&As this week: Advent International, Eli Lilly

Advent International has entered an agreement to purchase Sanofi’s European generics business Zentiva for €1.9bn ($2.2bn). Advent intends to invest...Read More... The post M&As this week: Adv...

Sanofi Agrees to sell Generics to Advent

French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9 billion. Negot...

Sanofi, Advent finalize negotiations for acquisition of Zentiva

Sanofi and Advent International have completed negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the companies have signed a Share Purchase Agreement wo...

Sanofi concludes sale of Zentiva to Advent for $2.2bn

Sanofi has closed the divestiture of its European generics business Zentiva to private equity firm Advent International for a total...Read More... The post Sanofi concludes sale of Zentiva to Advent f...

Advent acquires Sanofi’s generics business for €1.9bn

US-based private equity firm Advent International has concluded negotiations and signed a share purchase agreement to acquire Sanofi’s generics business...Read More... The post Advent acquires Sanof...

M&As this week: Advent International, Roche, Clinigen Group

Advent International has completed an acquisition of Sanofi’s European generics business Zentiva. Worth €1.9bn ($2.2bn), the acquisition follows a share...Read More... The post M&As this week...

Advent to Acquire Sanofi\'s Generics Biz in Europe

Sanofi and Advent finalize negotiations for the acquisition of Zentiva

KaNDy Therapeutics raises £25mm in Series C round

UK-based KaNDy Therapeutics (female sex-hormone related conditions) completed a £25mm ($32.2mm) Series C round from new backer Longitude Capital, along with returning investors Advent Life Sciences, ...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [347 Associated PubMed Articles listed on BioPortfolio]

Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya.

In Kenya, HIV testing during first ANC visit is standard practice for pregnant women. Despite a policy promoting male partner testing in ANC, few male partners accompany their partners for HIV testing...

Prevalence of HIV infection, access to HIV care, and response to antiretroviral therapy among partners of HIV-infected individuals in Thailand.

Health care providers usually focus on index HIV-infected patients and seldom obtain information from their partners. We aimed to determine HIV-preventative measures among couples, the prevalence of H...

A Misguided Venture: Presidential Fitness and the Duty to Warn.

Commentary on "A Misguided Venture: Presidential Fitness and the Duty to Warn".

Dialysis-Facility Joint-Venture Ownership - Hidden Conflicts of Interest.

Clinical Trials [412 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Advent™ Cervical Disc Versus Anterior Cervical Discectomy and Fusion(ACDF) for Treatment of One Level Degenerative Disc Disease (IDE Study)

The purpose of this study is to establish the safety and effectiveness of the Advent™ Cervical Disc compared to Anterior Cervical Discectomy and Fusion (ACDF) in treating degenerative di...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Companies [1660 Associated Companies listed on BioPortfolio]

Advent Venture Partners

Advent Venture Partners is one of the most experienced technology venture capital firms in the UK. Established in 1981 it invests in both the Information and Communications Technology and Life Science...

Avila Therapeutics, Inc.

Avila focuses on design and development of targeted covalent drugs to achieve best-in-class outcomes that cannot be achieved through traditional chemistries. This approach is call...

Advent Consumer Healthcare, LLC

Advent Consumer Healthcare, LLC is dedicated to delivering innovative consumer products to help physicians and healthcare providers increase a patient’s overall awareness, in...

Stromedix, Inc.

Stromedix is a privately held biotechnology company based in Cambridge, Massachusetts, focused on innovative therapies for fibrotic organ failure. Investors in Stromedix include A...

Direct Flow Medical, Inc.

Founded in 2004, the Company is headquartered in Santa Rosa, California, has a second manufacturing facility in Lake Forest, CA and employs 75 people. The Company’s unique im...

More Information about "Advent Venture Partners" on BioPortfolio

We have published hundreds of Advent Venture Partners news stories on BioPortfolio along with dozens of Advent Venture Partners Clinical Trials and PubMed Articles about Advent Venture Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advent Venture Partners Companies in our database. You can also find out about relevant Advent Venture Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record